0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global HLA Typing Services Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-16Z17037
Home | Market Reports | Science| Biological Sciences
Global HLA Typing Services Market Research Report 2024
BUY CHAPTERS

Global HLA Typing Services Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-16Z17037
Report
November 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

HLA Typing Services Market

The global HLA Typing Services market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Human leukocyte antigen (HLA), also known as transplantation antigen, is related to allogeneic tissue and organ transplantation and graft rejection. HLA tissue matching is one of the important factors affecting the survival rate of organ transplantation, hematopoietic stem cell transplantation and the quality of life of the recipient. HLA genes are highly polymorphic and determine the polymorphism of the expressed HLA antigen molecules. Currently, genotyping detection technology is mainly used for HLA typing. Compared with serological and cytological methods, it has higher sensitivity and accuracy and can detect more types.
From a downstream perspective, Clinical accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
HLA Typing Services leading manufacturers including Novogene, Abace Biology, Illumina, IGE Bio, CapitalBio Technology, Thermo Fisher Scientific, TBG Diagnostics, ProImmune, CD Genomics, CareDx, etc., dominate supply; the top five capture approximately % of global revenue, with Novogene leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global HLA Typing Services market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of HLA Typing Services Market Report

Report Metric Details
Report Name HLA Typing Services Market
Segment by Type
  • Serotyping
  • DNA Typing
Segment by Application
  • Clinical
  • Scientific Research
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novogene, Abace Biology, Illumina, IGE Bio, CapitalBio Technology, Thermo Fisher Scientific, TBG Diagnostics, ProImmune, CD Genomics, CareDx, Creative Biolabs, Cellecta, GenDx
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the HLA Typing Services study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the HLA Typing Services Market report?

Ans: The main players in the HLA Typing Services Market are Novogene, Abace Biology, Illumina, IGE Bio, CapitalBio Technology, Thermo Fisher Scientific, TBG Diagnostics, ProImmune, CD Genomics, CareDx, Creative Biolabs, Cellecta, GenDx

What are the Application segmentation covered in the HLA Typing Services Market report?

Ans: The Applications covered in the HLA Typing Services Market report are Clinical, Scientific Research

What are the Type segmentation covered in the HLA Typing Services Market report?

Ans: The Types covered in the HLA Typing Services Market report are Serotyping, DNA Typing

1 Study Coverage
1.1 Introduction to HLA Typing Services: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global HLA Typing Services Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Serotyping
1.2.3 DNA Typing
1.3 Market Segmentation by Application
1.3.1 Global HLA Typing Services Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global HLA Typing Services Revenue Estimates and Forecasts 2020-2031
2.2 Global HLA Typing Services Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global HLA Typing Services Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global HLA Typing Services Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Serotyping Market Size by Players
3.3.2 DNA Typing Market Size by Players
3.4 Global HLA Typing Services Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global HLA Typing Services Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global HLA Typing Services Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America HLA Typing Services Market Size by Type (2020-2031)
6.4 North America HLA Typing Services Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America HLA Typing Services Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe HLA Typing Services Market Size by Type (2020-2031)
7.4 Europe HLA Typing Services Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe HLA Typing Services Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific HLA Typing Services Market Size by Type (2020-2031)
8.4 Asia-Pacific HLA Typing Services Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific HLA Typing Services Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America HLA Typing Services Market Size by Type (2020-2031)
9.4 Central and South America HLA Typing Services Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America HLA Typing Services Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa HLA Typing Services Market Size by Type (2020-2031)
10.4 Middle East and Africa HLA Typing Services Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa HLA Typing Services Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Novogene
11.1.1 Novogene Corporation Information
11.1.2 Novogene Business Overview
11.1.3 Novogene HLA Typing Services Product Features and Attributes
11.1.4 Novogene HLA Typing Services Revenue and Gross Margin (2020-2025)
11.1.5 Novogene HLA Typing Services Revenue by Product in 2024
11.1.6 Novogene HLA Typing Services Revenue by Application in 2024
11.1.7 Novogene HLA Typing Services Revenue by Geographic Area in 2024
11.1.8 Novogene HLA Typing Services SWOT Analysis
11.1.9 Novogene Recent Developments
11.2 Abace Biology
11.2.1 Abace Biology Corporation Information
11.2.2 Abace Biology Business Overview
11.2.3 Abace Biology HLA Typing Services Product Features and Attributes
11.2.4 Abace Biology HLA Typing Services Revenue and Gross Margin (2020-2025)
11.2.5 Abace Biology HLA Typing Services Revenue by Product in 2024
11.2.6 Abace Biology HLA Typing Services Revenue by Application in 2024
11.2.7 Abace Biology HLA Typing Services Revenue by Geographic Area in 2024
11.2.8 Abace Biology HLA Typing Services SWOT Analysis
11.2.9 Abace Biology Recent Developments
11.3 Illumina
11.3.1 Illumina Corporation Information
11.3.2 Illumina Business Overview
11.3.3 Illumina HLA Typing Services Product Features and Attributes
11.3.4 Illumina HLA Typing Services Revenue and Gross Margin (2020-2025)
11.3.5 Illumina HLA Typing Services Revenue by Product in 2024
11.3.6 Illumina HLA Typing Services Revenue by Application in 2024
11.3.7 Illumina HLA Typing Services Revenue by Geographic Area in 2024
11.3.8 Illumina HLA Typing Services SWOT Analysis
11.3.9 Illumina Recent Developments
11.4 IGE Bio
11.4.1 IGE Bio Corporation Information
11.4.2 IGE Bio Business Overview
11.4.3 IGE Bio HLA Typing Services Product Features and Attributes
11.4.4 IGE Bio HLA Typing Services Revenue and Gross Margin (2020-2025)
11.4.5 IGE Bio HLA Typing Services Revenue by Product in 2024
11.4.6 IGE Bio HLA Typing Services Revenue by Application in 2024
11.4.7 IGE Bio HLA Typing Services Revenue by Geographic Area in 2024
11.4.8 IGE Bio HLA Typing Services SWOT Analysis
11.4.9 IGE Bio Recent Developments
11.5 CapitalBio Technology
11.5.1 CapitalBio Technology Corporation Information
11.5.2 CapitalBio Technology Business Overview
11.5.3 CapitalBio Technology HLA Typing Services Product Features and Attributes
11.5.4 CapitalBio Technology HLA Typing Services Revenue and Gross Margin (2020-2025)
11.5.5 CapitalBio Technology HLA Typing Services Revenue by Product in 2024
11.5.6 CapitalBio Technology HLA Typing Services Revenue by Application in 2024
11.5.7 CapitalBio Technology HLA Typing Services Revenue by Geographic Area in 2024
11.5.8 CapitalBio Technology HLA Typing Services SWOT Analysis
11.5.9 CapitalBio Technology Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Corporation Information
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific HLA Typing Services Product Features and Attributes
11.6.4 Thermo Fisher Scientific HLA Typing Services Revenue and Gross Margin (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 TBG Diagnostics
11.7.1 TBG Diagnostics Corporation Information
11.7.2 TBG Diagnostics Business Overview
11.7.3 TBG Diagnostics HLA Typing Services Product Features and Attributes
11.7.4 TBG Diagnostics HLA Typing Services Revenue and Gross Margin (2020-2025)
11.7.5 TBG Diagnostics Recent Developments
11.8 ProImmune
11.8.1 ProImmune Corporation Information
11.8.2 ProImmune Business Overview
11.8.3 ProImmune HLA Typing Services Product Features and Attributes
11.8.4 ProImmune HLA Typing Services Revenue and Gross Margin (2020-2025)
11.8.5 ProImmune Recent Developments
11.9 CD Genomics
11.9.1 CD Genomics Corporation Information
11.9.2 CD Genomics Business Overview
11.9.3 CD Genomics HLA Typing Services Product Features and Attributes
11.9.4 CD Genomics HLA Typing Services Revenue and Gross Margin (2020-2025)
11.9.5 CD Genomics Recent Developments
11.10 CareDx
11.10.1 CareDx Corporation Information
11.10.2 CareDx Business Overview
11.10.3 CareDx HLA Typing Services Product Features and Attributes
11.10.4 CareDx HLA Typing Services Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Creative Biolabs
11.11.1 Creative Biolabs Corporation Information
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs HLA Typing Services Product Features and Attributes
11.11.4 Creative Biolabs HLA Typing Services Revenue and Gross Margin (2020-2025)
11.11.5 Creative Biolabs Recent Developments
11.12 Cellecta
11.12.1 Cellecta Corporation Information
11.12.2 Cellecta Business Overview
11.12.3 Cellecta HLA Typing Services Product Features and Attributes
11.12.4 Cellecta HLA Typing Services Revenue and Gross Margin (2020-2025)
11.12.5 Cellecta Recent Developments
11.13 GenDx
11.13.1 GenDx Corporation Information
11.13.2 GenDx Business Overview
11.13.3 GenDx HLA Typing Services Product Features and Attributes
11.13.4 GenDx HLA Typing Services Revenue and Gross Margin (2020-2025)
11.13.5 GenDx Recent Developments
12 HLA Typing ServicesIndustry Chain Analysis
12.1 HLA Typing Services Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 HLA Typing Services Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global HLA Typing Services Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
 Table 1. Global HLA Typing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global HLA Typing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global HLA Typing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global HLA Typing Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global HLA Typing Services Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global HLA Typing Services Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global HLA Typing Services Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global HLA Typing Services by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in HLA Typing Services as of 2024)
 Table 11. Global HLA Typing Services Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global HLA Typing Services Companies Headquarters
 Table 13. Global HLA Typing Services Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global HLA Typing Services Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global HLA Typing Services Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global HLA Typing Services Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global HLA Typing Services Revenue by Application (2026-2031) & (US$ Million)
 Table 21. HLA Typing Services High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America HLA Typing Services Growth Accelerators and Market Barriers
 Table 25. North America HLA Typing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe HLA Typing Services Growth Accelerators and Market Barriers
 Table 27. Europe HLA Typing Services Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific HLA Typing Services Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific HLA Typing Services Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America HLA Typing Services Investment Opportunities and Key Challenges
 Table 31. Central and South America HLA Typing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa HLA Typing Services Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa HLA Typing Services Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Novogene Corporation Information
 Table 35. Novogene Description and Major Businesses
 Table 36. Novogene Product Features and Attributes
 Table 37. Novogene Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Novogene Revenue Proportion by Product in 2024
 Table 39. Novogene Revenue Proportion by Application in 2024
 Table 40. Novogene Revenue Proportion by Geographic Area in 2024
 Table 41. Novogene HLA Typing Services SWOT Analysis
 Table 42. Novogene Recent Developments
 Table 43. Abace Biology Corporation Information
 Table 44. Abace Biology Description and Major Businesses
 Table 45. Abace Biology Product Features and Attributes
 Table 46. Abace Biology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Abace Biology Revenue Proportion by Product in 2024
 Table 48. Abace Biology Revenue Proportion by Application in 2024
 Table 49. Abace Biology Revenue Proportion by Geographic Area in 2024
 Table 50. Abace Biology HLA Typing Services SWOT Analysis
 Table 51. Abace Biology Recent Developments
 Table 52. Illumina Corporation Information
 Table 53. Illumina Description and Major Businesses
 Table 54. Illumina Product Features and Attributes
 Table 55. Illumina Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Illumina Revenue Proportion by Product in 2024
 Table 57. Illumina Revenue Proportion by Application in 2024
 Table 58. Illumina Revenue Proportion by Geographic Area in 2024
 Table 59. Illumina HLA Typing Services SWOT Analysis
 Table 60. Illumina Recent Developments
 Table 61. IGE Bio Corporation Information
 Table 62. IGE Bio Description and Major Businesses
 Table 63. IGE Bio Product Features and Attributes
 Table 64. IGE Bio Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. IGE Bio Revenue Proportion by Product in 2024
 Table 66. IGE Bio Revenue Proportion by Application in 2024
 Table 67. IGE Bio Revenue Proportion by Geographic Area in 2024
 Table 68. IGE Bio HLA Typing Services SWOT Analysis
 Table 69. IGE Bio Recent Developments
 Table 70. CapitalBio Technology Corporation Information
 Table 71. CapitalBio Technology Description and Major Businesses
 Table 72. CapitalBio Technology Product Features and Attributes
 Table 73. CapitalBio Technology Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. CapitalBio Technology Revenue Proportion by Product in 2024
 Table 75. CapitalBio Technology Revenue Proportion by Application in 2024
 Table 76. CapitalBio Technology Revenue Proportion by Geographic Area in 2024
 Table 77. CapitalBio Technology HLA Typing Services SWOT Analysis
 Table 78. CapitalBio Technology Recent Developments
 Table 79. Thermo Fisher Scientific Corporation Information
 Table 80. Thermo Fisher Scientific Description and Major Businesses
 Table 81. Thermo Fisher Scientific Product Features and Attributes
 Table 82. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Thermo Fisher Scientific Recent Developments
 Table 84. TBG Diagnostics Corporation Information
 Table 85. TBG Diagnostics Description and Major Businesses
 Table 86. TBG Diagnostics Product Features and Attributes
 Table 87. TBG Diagnostics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. TBG Diagnostics Recent Developments
 Table 89. ProImmune Corporation Information
 Table 90. ProImmune Description and Major Businesses
 Table 91. ProImmune Product Features and Attributes
 Table 92. ProImmune Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. ProImmune Recent Developments
 Table 94. CD Genomics Corporation Information
 Table 95. CD Genomics Description and Major Businesses
 Table 96. CD Genomics Product Features and Attributes
 Table 97. CD Genomics Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. CD Genomics Recent Developments
 Table 99. CareDx Corporation Information
 Table 100. CareDx Description and Major Businesses
 Table 101. CareDx Product Features and Attributes
 Table 102. CareDx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. CareDx Recent Developments
 Table 104. Creative Biolabs Corporation Information
 Table 105. Creative Biolabs Description and Major Businesses
 Table 106. Creative Biolabs Product Features and Attributes
 Table 107. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Creative Biolabs Recent Developments
 Table 109. Cellecta Corporation Information
 Table 110. Cellecta Description and Major Businesses
 Table 111. Cellecta Product Features and Attributes
 Table 112. Cellecta Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Cellecta Recent Developments
 Table 114. GenDx Corporation Information
 Table 115. GenDx Description and Major Businesses
 Table 116. GenDx Product Features and Attributes
 Table 117. GenDx Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. GenDx Recent Developments
 Table 119. Raw Materials Key Suppliers
 Table 120. Distributors List
 Table 121. Market Trends and Market Evolution
 Table 122. Market Drivers and Opportunities
 Table 123. Market Challenges, Risks, and Restraints
 Table 124. Research Programs/Design for This Report
 Table 125. Key Data Information from Secondary Sources
 Table 126. Key Data Information from Primary Sources


List of Figures
 Figure 1. HLA Typing Services Product Picture
 Figure 2. Global HLA Typing Services Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Serotyping Product Picture
 Figure 4. DNA Typing Product Picture
 Figure 5. Global HLA Typing Services Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Clinical
 Figure 7. Scientific Research
 Figure 8. HLA Typing Services Report Years Considered
 Figure 9. Global HLA Typing Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 11. Global HLA Typing Services Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global HLA Typing Services Revenue Market Share by Region (2020-2031)
 Figure 13. Global HLA Typing Services Revenue Market Share Ranking (2024)
 Figure 14. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 15. Serotyping Revenue Market Share by Player in 2024
 Figure 16. DNA Typing Revenue Market Share by Player in 2024
 Figure 17. Global HLA Typing Services Revenue Market Share by Type (2020-2031)
 Figure 18. Global HLA Typing Services Revenue Market Share by Application (2020-2031)
 Figure 19. North America HLA Typing Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 20. North America Top 5 Players HLA Typing Services Revenue (US$ Million) in 2024
 Figure 21. North America HLA Typing Services Revenue (US$ Million) by Type (2020 - 2031)
 Figure 22. North America HLA Typing Services Revenue (US$ Million) by Application (2020-2031)
 Figure 23. US HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 24. Canada HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 25. Mexico HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 26. Europe HLA Typing Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. Europe Top 5 Players HLA Typing Services Revenue (US$ Million) in 2024
 Figure 28. Europe HLA Typing Services Revenue (US$ Million) by Type (2020-2031)
 Figure 29. Europe HLA Typing Services Revenue (US$ Million) by Application (2020-2031)
 Figure 30. Germany HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 31. France HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 32. U.K. HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 33. Italy HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 34. Russia HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific HLA Typing Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Top 8 Players HLA Typing Services Revenue (US$ Million) in 2024
 Figure 37. Asia-Pacific HLA Typing Services Revenue (US$ Million) by Type (2020-2031)
 Figure 38. Asia-Pacific HLA Typing Services Revenue (US$ Million) by Application (2020-2031)
 Figure 39. Indonesia HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 40. Japan HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 41. South Korea HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 42. Australia HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 43. India HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 44. Indonesia HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 45. Vietnam HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 46. Malaysia HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 47. Philippines HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 48. Singapore HLA Typing Services Revenue (2020-2031) & (US$ Million)
 Figure 49. Central and South America HLA Typing Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Central and South America Top 5 Players HLA Typing Services Revenue (US$ Million) in 2024
 Figure 51. Central and South America HLA Typing Services Revenue (US$ Million) by Type (2020-2031)
 Figure 52. Central and South America HLA Typing Services Revenue (US$ Million) by Application (2020-2031)
 Figure 53. Brazil HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 54. Argentina HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 55. Middle East and Africa HLA Typing Services Revenue YoY (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Top 5 Players HLA Typing Services Revenue (US$ Million) in 2024
 Figure 57. South America HLA Typing Services Revenue (US$ Million) by Type (2020-2031)
 Figure 58. Middle East and Africa HLA Typing Services Revenue (US$ Million) by Application (2020-2031)
 Figure 59. GCC Countries HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 60. Israel HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 61. Egypt HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 62. South Africa HLA Typing Services Revenue (2020-2025) & (US$ Million)
 Figure 63. HLA Typing Services Industry Chain Mapping
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart